title: Reduction of phosphatidylcholine hydroperoxide by apolipoprotein A-I: purification of the hydroperoxide-reducing proteins from human blood plasma.
abstract: Plasma glutathione peroxidase (GSHPx) has been suggested to reduce submicromolar levels of free fatty acid hydroperoxides and phosphatidylcholine hydroperoxides (PC-OOH), and therefore these hydroperoxides are undetectable in human blood plasma. The capacity for the reduction should be about 2.5 microM as the level of glutathione in human plasma is about 5 microM. However, 2 h of aerobic incubation of 58 microM PC-OOH in human plasma at 37 degrees C resulted in the formation of 36 microM phosphatidylcholine hydroxide (PC-OH). The presence of PC-OOH-reducing protein other than plasma GSHPx was suggested by the results. a) The same rates of PC-OOH decay and PC-OH formation were observed in both sera from rats with selenium-deficient and selenium-supplemented diet; b) the PC-OOH-reducing activity was observed only in the high molecular weight fraction but not in the low molecular weight fraction; and c) albumin did not work as a reducing substrate of plasma GSHPx. We have isolated two hydroperoxide-reducing protein fractions from human plasma by a sequential purification scheme, comprising an ammonium sulfate precipitation followed by sequential chromatography on anion exchange, hydrophobic interaction, and heparin columns. One of the proteins was identified as apolipoprotein A-I by N-terminal amino acid sequence analysis. Moreover, the hydroperoxide-reducing activity of one of the fractions was inhibited almost completely by the addition of anti-apolipoprotein A-I antibody. These findings demonstrate that apolipoprotein A-I in high density lipoprotein can reduce PC-OOH to PC-OH.
authors.affiliation: Research Center for Advanced Science and Technology, University of Tokyo, Japan.
authors.forename: R
authors.initials: R
authors.lastname: Mashima
authors.forename: Y
authors.initials: Y
authors.lastname: Yamamoto
authors.forename: S
authors.initials: S
authors.lastname: Yoshimura
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D016632:Apolipoprotein A-I / Q000097:blood* / Q000737:chemistry / Q000302:isolation & purification; D002852:Chromatography, Ion Exchange; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005979:Glutathione Peroxidase / Q000097:blood*; D006801:Humans; D007700:Kinetics; D008297:Male; D010084:Oxidation-Reduction; D010713:Phosphatidylcholines / Q000097:blood*; D051381:Rats; D017208:Rats, Wistar; D012643:Selenium / Q000172:deficiency / Q000494:pharmacology; D012709:Serum Albumin / Q000378:metabolism*
chemical_list: D016632:Apolipoprotein A-I; D005230:Fatty Acids, Nonesterified; D010713:Phosphatidylcholines; D012709:Serum Albumin; C057590:phosphatidylcholine hydroperoxide; D005979:Glutathione Peroxidase; D012643:Selenium